Plus Therapeutics reported $18.03M in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Baxter International USD 6.85B 25M Mar/2026
Cerus USD 174.38M 7.26M Dec/2025
Dr.Reddys Laboratories INR 301.79B 4.24B Mar/2026
Haemonetics USD 834.88M 108.8M Mar/2026
Infinity Pharmaceuticals USD 19.91M 8.46M Jun/2023
Northwest Biotherapeutics USD 7.2M 1.04M Sep/2025
Plus Therapeutics USD 18.03M 2.86M Mar/2026
Sanofi EUR 30.16B 789M Mar/2026
Starpharma Holdings AUD 24.24M 1.68M Dec/2025
Sun Pharmaceuticals INR 638.6B 37.24B Mar/2026
Teva Pharmaceutical Industries USD 13.71B 236M Mar/2026